SFCM
ENTA icon

Seven Fleet Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Seven Fleet Capital Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,270
Closed -$35.8K – 123
2025
Q4 		$35.8K Buy
+2,270
New +$28.8K 0.02% 81

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Seven Fleet Capital Management's ENTA Position: Q1 2026 in Review

Seven Fleet Capital Management sold out of Enanta Pharmaceuticals (ENTA) in Q1 2026, closing a stake of 2,270 shares — an estimated $35.8K sold.

Seven Fleet Capital Management first reported a position in ENTA in Q4 2025 and held it in 1 quarter. The position peaked at $35.8K in Q4 2025. 133 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Seven Fleet Capital Management reported no remaining Enanta Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Seven Fleet Capital Management sold 2,270 Enanta Pharmaceuticals shares in Q1 2026, an estimated $35.8K.
  • Seven Fleet Capital Management first reported a position in Enanta Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Seven Fleet Capital Management's Enanta Pharmaceuticals position peaked at $35.8K in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.